Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Bioorg Med Chem Lett ; 20(20): 6129-32, 2010 Oct 15.
Article in English | MEDLINE | ID: mdl-20833039

ABSTRACT

A series of azulene-based derivatives were synthesized as potent inhibitors for receptor tyrosine kinases such as FMS-like tyrosine kinase 3 (FLT-3). Systematic side chain modification of prototype 1a was carried out through SAR studies. Analogue 22 was identified from this series and found to be one of the most potent FLT-3 inhibitors, with good pharmaceutical properties, superior efficacy, and tolerability in a tumor xenograft model.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/therapeutic use , Azulenes/chemistry , Azulenes/therapeutic use , Leukemia, Myeloid, Acute/drug therapy , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , Animals , Antineoplastic Agents/blood , Antineoplastic Agents/pharmacology , Azulenes/blood , Azulenes/pharmacology , Cell Line, Tumor , Cell Proliferation , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Rats , Receptor Protein-Tyrosine Kinases/metabolism , fms-Like Tyrosine Kinase 3/antagonists & inhibitors
2.
Bioorg Med Chem ; 18(13): 4674-86, 2010 Jul 01.
Article in English | MEDLINE | ID: mdl-20570526

ABSTRACT

A series of new ureidoindolin-2-one derivatives were synthesized and evaluated as inhibitors of receptor tyrosine kinases. Investigation of structure-activity relationships at positions 5, 6, and 7 of the oxindole skeleton led to the identification of 6-ureido-substituted 3-pyrrolemethylidene-2-oxindole derivatives that potently inhibited both the vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) families of receptor tyrosine kinases. Several derivatives showed potency against the PDGFR inhibiting both its enzymatic and cellular functions in the single-digit nanomolar range. Among them, compound 35 was a potent inhibitor against tyrosine kinases, including VEGFR and PDGFR families, as well as Aurora kinases. Inhibitor 36 (non-substituted on the pyrrole or phenyl ring) had a moderate pharmacokinetic profile and completely inhibited tumor growth initiated with the myeloid leukemia cell line, MV4-11, in a subcutaneous xenograft model in BALB/c nude mice.


Subject(s)
ErbB Receptors/antagonists & inhibitors , Indoles/chemistry , Protein Kinase Inhibitors/chemical synthesis , Protein Serine-Threonine Kinases/antagonists & inhibitors , Pyrroles/chemistry , Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors , Urea/analogs & derivatives , Animals , Aurora Kinases , Binding Sites , Cell Line, Tumor , Computer Simulation , Drug Screening Assays, Antitumor , ErbB Receptors/metabolism , Humans , Indoles/therapeutic use , Indoles/toxicity , Leukemia, Myeloid/drug therapy , Mice , Oxindoles , Protein Kinase Inhibitors/therapeutic use , Protein Kinase Inhibitors/toxicity , Protein Serine-Threonine Kinases/metabolism , Pyrroles/therapeutic use , Pyrroles/toxicity , Receptors, Platelet-Derived Growth Factor/metabolism , Structure-Activity Relationship , Transplantation, Heterologous , Urea/chemistry , Urea/therapeutic use , Urea/toxicity
3.
Life Sci ; 84(25-26): 915-22, 2009 Jun 19.
Article in English | MEDLINE | ID: mdl-19393247

ABSTRACT

AIMS: To address the possibility that sennoside B inhibition of cell proliferation is mediated via interference with platelet-derived growth factor (PDGF) signaling. MAIN METHODS: Human osteosarcoma MG63 cells were treated with PDGF in the presence or absence of sennoside B. Activation of the PDGF signaling pathway was monitored using western immunoblotting with specific antibodies against the PDGF receptor, phosphotyrosine and components of the downstream signaling cascade. Activation of cell metabolism and proliferation was assessed by chromogenic reduction of MTT. KEY FINDINGS: Sennoside B was found to inhibit PDGF-BB-induced phosphorylation of the PDGF receptor (PDGFR) in human MG63 osteosarcoma cells. Downstream signaling was also affected; pre-incubation of PDGF-BB with sennoside B inhibited the phosphorylation of pathway components including Ak strain transforming protein (AKT), signal transducer and activator of transcription 5 (STAT-5) and extracellular signal-regulated kinase 1/2 (ERK1/2). Further, we found that sennoside B can bind directly to the extracellular domains of both PDGF-BB and the PDGF-beta receptor (PDGFR-beta). The effect was specific for sennoside B; other similar compounds including aloe-emodin, rhein and the meso isomer (sennoside A) failed to inhibit PDGFR activation or downstream signaling. Sennoside B also inhibited PDGF-BB stimulation of MG63 cell proliferation. SIGNIFICANCE: These results indicate that sennoside B can inhibit PDGF-stimulated cell proliferation by binding to PDGF-BB and its receptor and by down-regulating the PDGFR-beta signaling pathway. Sennoside B is therefore of potential utility in the treatment of proliferative diseases in which PDGF signaling plays a central role.


Subject(s)
Anthraquinones/pharmacology , Cathartics/pharmacology , Cell Proliferation/drug effects , Platelet-Derived Growth Factor/metabolism , Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors , Receptors, Platelet-Derived Growth Factor/metabolism , Anthraquinones/metabolism , Becaplermin , Cathartics/metabolism , Cell Line, Tumor , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Oncogene Protein v-akt/antagonists & inhibitors , Oncogene Protein v-akt/metabolism , Osteosarcoma/drug therapy , Phosphorylation/drug effects , Protein Binding , Protein Structure, Tertiary , Proto-Oncogene Proteins c-sis , Receptor, Platelet-Derived Growth Factor beta/antagonists & inhibitors , Receptor, Platelet-Derived Growth Factor beta/metabolism , STAT5 Transcription Factor/antagonists & inhibitors , STAT5 Transcription Factor/metabolism , Senna Extract , Sennosides , Signal Transduction/drug effects
4.
Nat Prod Res ; 22(13): 1151-7, 2008.
Article in English | MEDLINE | ID: mdl-18855215

ABSTRACT

One new compound, 10-hydroxy-gamma-dodecalactone (1) and three natural new compounds, 11-hydroxy-gamma-dodecalactone (2), 2-(2-hydroxyethyl)phenol (3) and 12-hydroxydodecanoic acid methyl ester (4), together with eight known compounds, ergostatrien-3beta-ol, ergosterol peroxide, methyl (4-hydroxyphenyl)acetate, vanillin, 4-hydroxybenzaldehyde, hexadecanoic acid, 5-methoxymethylfuran-2-carbaldehyde and 5-hydroxymethylfuran-2-carbaldehyde, all were isolated from the submerged whole broth of Antrodia camphorata. The structures of 1 and 2 were principally elucidated by spectral evidence and the absolute configuration was elucidated by the modified Mosher's method.


Subject(s)
Antrodia/chemistry , Fruiting Bodies, Fungal/chemistry , Lactones/chemistry , Phenol/chemistry , Culture Media, Conditioned/chemistry , Lactones/isolation & purification , Magnetic Resonance Spectroscopy , Medicine, Chinese Traditional , Molecular Structure , Phenol/isolation & purification
5.
FEMS Microbiol Lett ; 276(2): 202-6, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17956427

ABSTRACT

Aspartokinase III, encoded by lysC, is responsible for the first step of lysine biosynthesis in Escherichia coli. In this study, a lysC knockout E. coli W3110 strain was generated to study the differential gene expression profiles of wild type and lysC knockout strains. Several significant changes were observed, including biosynthesis of lysine, oxaloacetate, alpha-ketoglutarate and glutamate genes. Genes related to transporters and heat shock proteins were also affected by lysC knockout. The results indicated that the lysC knockout strain exhibited some phenomena similar to lysine starvation. The data generated by this study further clarify the systematic role of lysC in lysine biosynthesis.


Subject(s)
Aspartate Kinase/genetics , Escherichia coli Proteins/genetics , Escherichia coli/genetics , Gene Expression Regulation, Bacterial , Escherichia coli/physiology , Gene Deletion , Gene Expression Profiling , Oligonucleotide Array Sequence Analysis
6.
J Agric Food Chem ; 55(13): 5007-12, 2007 Jun 27.
Article in English | MEDLINE | ID: mdl-17536816

ABSTRACT

Five polysaccharide fractions (AC-1, AC-2, AC-3, AC-4, and AC-5) were obtained after systemic solvent extractions and precipitations from Antrodia camphorata mycelia with yields of 2.92, 10.38, 1.65, 0.34, and 1.64%, respectively. Gel permeation chromatography (GPC) analysis showed that the distribution of mean molecular mass of the fractionated polysaccharides was in the range of 394-940 kDa. The proximate compositions from each polysaccharide fraction revealed that all fractions belonged to the category of glycoprotein, having ratios of carbohydrate/protein ranging from 0.29 to 10.79 (w/w). Glucose or galactose was the major monosaccharide in all fractions except fraction AC-2, which has a mean molecular mass of 394 kDa with lyxose as the most prominent constituent. In the evaluation of the DPPH* radical scavenging capability, fraction AC-1 and AC-2 polysaccharides showed the better capabilities, around 74.5 and 50.5%, respectively, compared to the reference control of Trolox (87.5%) at a concentration of 1 microM. In testing with macrophage RAW264.7 cells, fraction AC-2 demonstrated a rather potent anti-inflammatory capability. Furthermore, the lipopolysaccharide-induced NO production and the protein expression by the inducible nitric oxide synthase (iNOS) gene were inhibited, respectively, in a dose-dependent (50-200 microg/mL) manner by fraction AC-2 polysaccharide.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Mycelium/chemistry , Polyporales/chemistry , Polysaccharides/chemistry , Polysaccharides/pharmacology , Animals , Cell Line , Chemical Fractionation , Chromatography, Gel , Macrophages/drug effects , Mice , Monosaccharides/analysis , Nitric Oxide Synthase Type II/antagonists & inhibitors , Polysaccharides/isolation & purification
7.
Biotechnol Lett ; 29(8): 1287-92, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17520177

ABSTRACT

The promoters of high-affinity hexose transporter, HXT6 and HXT7, are sufficient for complementary expression of invertase to restore the growth of Saccharomyces cerevisiae in raffinose medium. The HXT7 promoter produced higher invertase activity at 139- and 30-fold of the basal activity in strains GN 3C.2 and W303-1, respectively. In addition, the HXT7 promoter expressed 3- to 9-fold more of enhanced green fluorescent protein than that of the constitutive ADH1 in three different S. cerevisiae strains, even during short-term incubation in glucose medium. Therefore, HXT7 promoter could be used for heterologous protein expression in S. cerevisiae.


Subject(s)
Biotechnology/methods , Hexoses/chemistry , Monosaccharide Transport Proteins/metabolism , Monosaccharide Transport Proteins/physiology , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae Proteins/physiology , Saccharomyces cerevisiae/metabolism , Cell Separation , Culture Media/metabolism , Flow Cytometry , Monosaccharide Transport Proteins/chemistry , Plasmids/metabolism , Promoter Regions, Genetic , Raffinose/chemistry , Time Factors , beta-Fructofuranosidase/metabolism
8.
J Surg Oncol ; 94(7): 631-8, 2006 Dec 01.
Article in English | MEDLINE | ID: mdl-17066421

ABSTRACT

BACKGROUND AND OBJECTIVES: Growth and metastasis of malignant tumors depend on the angiogenesis. The aim of this study was to elucidate the prognostic significance of angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) expression in advanced colorectal carcinoma. METHODS: Totally, 101 patients with surgically resected advanced colorectal carcinomas were enrolled. The tumor expressions of Ang-1 and Ang-2 were evaluated immunohistochemically, and their relationships with clinicopathological factors and prognosis were investigated. Tumor microvessel density (MVD) was also calculated and correlated with angiopoietin expression. RESULTS: Ang-1 and Ang-2 were detected in 26 (25.7%) and 45 (44.6%), respectively, of 101 cancerous lesions. Overexpression of Ang-1 was correlated with high MVD. Overexpression of Ang-2 was correlated with lymph node metastasis, venous invasion, preoperative carcinoembryonic antigen levels, and high MVD (P < or = 0.05). MVD was not significantly upregulated by Ang-1 expression, but was significantly upregulated by Ang-2 expression (P < or = 0.01). However, only patients with Ang-2 overexpression showed a significantly worse prognosis than those without Ang-2 overexpression. Multivariate analysis with logistic regression for 5-year survival revealed that cancerous stage and Ang-2 overexpression were independent prognostic indicators. CONCLUSIONS: The Ang-1 expression correlated with MVD. However, Ang-2 expression was a useful prognostic marker in the management of patients with advanced colorectal carcinoma.


Subject(s)
Angiopoietin-1/biosynthesis , Angiopoietin-2/biosynthesis , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Lymph Nodes/pathology , Aged , Colorectal Neoplasms/blood supply , Colorectal Neoplasms/surgery , Disease-Free Survival , Female , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Middle Aged , Multivariate Analysis , Neoplasm Invasiveness , Neoplasm Staging , Prognosis , Survival Rate
9.
Can J Microbiol ; 52(6): 570-4, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16788725

ABSTRACT

Strain W-10, originally identified as Trichoderma koningii, and its supposed mutant G-39, published for production and gene expression of cellulase and xylanase, demonstrated morphological characteristics distinct from those of T. koningii, respectively. To clarify the identification derived from morphological characteristics, several methods were used, including electrophoretic karyotyping, internal transcribed spacer (ITS) analysis of rDNA, and polymerase chain reaction (PCR) fingerprinting using the universal primer L45. All the molecular characteristics showed that strains G-39 and W-10 were identical to T. reesei and T. longibrachiatum, respectively. The results strongly supported that T. koningii G-39 and W-10 should be reassigned as T. reesei and T. longibrachiatum, respectively. Strain G-39 should be considered a mutant from T. reesei QM9414 whose spores were contaminated with those of strain W-10 during a laboratory operation. According to this, we declare that T. koningii G-39 and W-10 must be renamed as T. reesei and T. longibrachiatum, respectively.


Subject(s)
Cellulase/metabolism , Trichoderma/genetics , Cellulase/biosynthesis , DNA, Fungal/genetics , DNA, Ribosomal/genetics , DNA, Ribosomal Spacer/genetics , Electrophoresis/methods , Mycological Typing Techniques , Phylogeny , Polymerase Chain Reaction/methods , Species Specificity , Trichoderma/classification , Trichoderma/enzymology , Xylosidases/metabolism
10.
Cancer Lett ; 231(2): 215-27, 2006 Jan 18.
Article in English | MEDLINE | ID: mdl-16399223

ABSTRACT

Antrodia camphorata (A. camphorata) is well known in Taiwan as a traditional Chinese medicine, and it has been shown to exhibit antioxidant and anticancer effects. In this study, therefore, its ability to induce apoptosis in cultured MCF-7 breast cancer cells was studied. Treatment of the MCF-7 cells with a variety of concentrations of the fermented culture broth of A. camphorata (25-150 microg/ml) resulted in dose- and time-dependent sequences of events marked by apoptosis, as shown by loss of cell viability, chromatin condensation, internucleosomal DNA fragmentation, and sub-G1 phase accumulation. Furthermore, apoptosis in the MCF-7 cells was accompanied by the release of cytochrome c, activation of caspase 3, and specific proteolytic cleavage of poly (ADP-ribose) polymerase (PARP). Although, the A. camphorata-induced apoptosis was associated with Bax protein levels, negligible Bcl-2 reduction was observed. Interestingly, A. camphorata induced dose-dependent reactive oxygen species (ROS) generation in MCF-7 cells. Analysis of the data suggests that A. camphorata exerts antiproliferative action and growth inhibition on MCF-7 cells through apoptosis induction, and that it may have anticancer properties valuable for application in drug products.


Subject(s)
Apoptosis/drug effects , Breast Neoplasms/drug therapy , Drugs, Chinese Herbal/therapeutic use , G1 Phase/drug effects , Polyporales/chemistry , Reactive Oxygen Species/metabolism , Annexin A5/metabolism , Breast Neoplasms/pathology , Caspases/metabolism , Cell Proliferation/drug effects , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Female , Flow Cytometry , Humans , Poly(ADP-ribose) Polymerases/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Tumor Cells, Cultured , bcl-2-Associated X Protein/metabolism
11.
Toxicol Appl Pharmacol ; 205(3): 247-58, 2005 Jun 15.
Article in English | MEDLINE | ID: mdl-15922010

ABSTRACT

In mammals, CYP3A isozymes collectively comprise the largest portion of the liver and small intestinal CYP protein. They are involved in the metabolism of an extensive range of endogenous substrates and xenobiotics and make a significant contribution to the termination of the action of steroid hormones. A full-length cDNA of CYP3A gene, named CYP3A65, was cloned from zebrafish by RT-PCR. The CYP3A65 mRNA was initially transcribed only in the liver and intestine upon hatching of the zebrafish embryos. Like the human CYP3A genes, CYP3A65 transcription in the foregut region was enhanced by treatment of the zebrafish larvae with the steroid dexamethasone and the macrocyclic antibiotic rifampicin. Differing from mammalian CYP3A genes, CYP3A65 transcription was also elicited by 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) during early larval stages. Repression of AHR2 translation by antisense morpholino oligonucleotides abrogated both of constitutive and TCDD-stimulated CYP3A65 transcription in larval intestine. These findings suggested that the AHR2 signaling pathway plays an essential role in CYP3A65 transcription.


Subject(s)
Aryl Hydrocarbon Hydroxylases/genetics , Gene Expression Regulation, Developmental/drug effects , Larva/genetics , Oxidoreductases, N-Demethylating/genetics , Xenobiotics/pharmacology , Zebrafish Proteins/genetics , Zebrafish/genetics , Animals , Aryl Hydrocarbon Hydroxylases/drug effects , Aryl Hydrocarbon Hydroxylases/metabolism , Dexamethasone/pharmacology , Gene Expression Regulation, Developmental/genetics , In Situ Hybridization/methods , Intestines/drug effects , Intestines/embryology , Larva/drug effects , Larva/metabolism , Oligonucleotides, Antisense/pharmacology , Oxidoreductases, N-Demethylating/drug effects , Oxidoreductases, N-Demethylating/metabolism , Polychlorinated Dibenzodioxins/antagonists & inhibitors , Polychlorinated Dibenzodioxins/pharmacology , RNA, Messenger , Receptors, Aryl Hydrocarbon/antagonists & inhibitors , Receptors, Aryl Hydrocarbon/drug effects , Reverse Transcriptase Polymerase Chain Reaction/methods , Rifampin/pharmacology , Sequence Analysis, Protein/methods , Signal Transduction/drug effects , Signal Transduction/physiology , Xenobiotics/chemistry , Zebrafish/embryology , Zebrafish/metabolism , Zebrafish Proteins/antagonists & inhibitors , Zebrafish Proteins/drug effects , Zebrafish Proteins/metabolism
12.
Can J Microbiol ; 48(9): 831-40, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12455615

ABSTRACT

Molecular approaches including internal transcribed spacer (ITS) sequences of ribosomal DNA, universal primer polymerase chain reaction (UP-PCR) fingerprinting, and DNA-DNA hybridization were used to study the genetic relatedness of species within Trichoderma sect. Pachybasium. In the analysis of ITS and 5.8S sequences of ribosomal DNA, parsimony analysis demonstrated that forty-one strains were distributed into five main groups supported by high bootstrap values. The species of Trichoderma sect. Pachybasium were clustered into groups I, II, and IV, with the strains of Trichoderma fasculatum and Trichoderma strictipile forming a separate branch, an independent group V. Some species within each group showed nearly identical sequence differences (fewer than 1-3 bp). UP-PCR and DNA-DNA hybridization were further used to clarify the genetic relatedness of these species with highly similar ITS sequences. Highly similar or identical UP-PCR profiles and high values of DNA complementarity (>70%) were observed among some species, Trichoderma hamatum and Trichoderma pubescens; Trichoderma croceum, Trichoderma polysporum and Trichoderma album, Trichoderma crassum and Trichoderma flavofuscum; and Trichoderma strictipile and Trichoderma fasciculatum. Although every species can be differentiated morphologically, the species showed highly similar molecular characteristics in the above cases, indicating that they could be conspecific. However, in some cases (Trithoderma longipile, T. crassum and T. flavofuscum; Trichoderma fertile and Trichoderma minutisporum; Trichoderma tomentosum, Trichoderma inhamatum and Trichoderma harzianum) there were discriminative patterns of UP-PCR and (or) low levels (<50%) of DNA-DNA hybridization; even their ITS sequences were similar, suggesting a closely phylogenetic relationship.


Subject(s)
Trichoderma/classification , DNA Fingerprinting/methods , DNA, Fungal/analysis , DNA, Ribosomal Spacer/analysis , Molecular Sequence Data , Mycological Typing Techniques , Nucleic Acid Hybridization , Polymerase Chain Reaction , RNA, Ribosomal, 5.8S/genetics , Sequence Analysis, DNA , Trichoderma/genetics
13.
Gen Comp Endocrinol ; 127(3): 307-13, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12225774

ABSTRACT

Pit-1 is a pituitary-specific transcription factor, which regulates the expression of growth hormone, prolactin, and thyroid stimulating hormone-beta genes. We previously reported the expression of a Pit-1 gene from ayu (Plecoglossus altivelis), which is an important cultivated food fish in Taiwan and Japan. Comparison of ayu Pit-1 with that of salmon, turkey, and rodent, revealed that the Pit-1 structure is highly conserved through vertebrates, especially in POU-specific and POU-homeo domains. The variation among fish, bird, and mammal are mainly found in transactivation domain by alternative splicing and initiation. Three insertions were found. The gamma-insert in fish Pit-1 is homologous to the exon 2a of avian Pit-1, which is not found in mammals. The beta-insert of fish Pit-1 is homologous to the 28 amino acids (a.a.) and 26 a.a. insert of avian Pit-1 beta(*) and mammalian Pit-1 beta, respectively. An additional similarity was noticed between fish and bird, as both of them contain 7 a.a. insert that is not present in mammalian Pit-1. By site directed mutagenesis, we demonstrated that the beta, gamma, and the 7 a.a. inserts of ayu Pit-1 are critical for activation of zebrafish growth hormone promoter. The ayu Pit-1 protein was found to be expressed specifically in pituitary gland, and its mRNA was first detected at embryonic day 4, significantly increased at embryonic day 5, then sustained to time of hatching at day 8.


Subject(s)
DNA-Binding Proteins/genetics , Gene Expression , Osmeriformes/genetics , Pituitary Gland/metabolism , Transcription Factors/genetics , Transcriptional Activation/genetics , 3T3 Cells , Alternative Splicing , Animals , Conserved Sequence , Mice , Mutagenesis, Site-Directed , Osmeriformes/growth & development , Pituitary Gland/chemistry , Pituitary Gland/embryology , Promoter Regions, Genetic , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factor Pit-1 , Transfection , Zebrafish/genetics
14.
Protein Expr Purif ; 24(2): 292-301, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11858725

ABSTRACT

The pituitary-specific transcription factor Pit-1 belongs to the family of POU-domain proteins and is known to play an important role in the differentiation of pituitary cells. Here we report the complete nucleotide sequence of cDNA encoding Pit-1 from the brackish water fish, ayu (Plecoglossus altivelis). Nucleotide sequence analysis of 1910 bp of ayu Pit-1 cDNA revealed an open reading frame of 1074 bp that encodes a protein of 358 amino acids containing a POU-specific domain, POU homeodomain, and an STA (Ser/Thr-rich activation) transactivation domain. We inserted the coding region of Pit-1 cDNA, obtained by PCR, into a pET-20b(+) plasmid to produce recombinant Pit-1 in Escherichia coli BL21 (DE3) pLysS cells. Upon induction with isopropyl beta-D-thiogalactopyranoside, Pit-1 was expressed and accumulated as inclusion bodies in E. coli. The protein was then purified in one step by affinity chromatography on a nickel-nitrilotriacetic acid agarose column under denaturing conditions. This method yielded 0.7 mg of highly pure and stable protein per 200 ml of bacterial culture. A band of 40 kDa, resolved as recombinant ayu Pit-1 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, agrees well with the molecular mass calculated from the translated cDNA sequence. The purified recombinant Pit-1 was confirmed in vitro through Western blot analysis, using its monoclonal antibody. This monoclonal antibody detected Pit-1 in the nuclei of ayu developing pituitary by immunohistochemical reaction. It serves as a good reagent for the detection of ayu Pit-1 in situ.


Subject(s)
DNA-Binding Proteins/genetics , Fishes , Transcription Factors/genetics , Amino Acid Sequence , Animals , Antibodies, Monoclonal , Base Sequence , Blotting, Western , DNA-Binding Proteins/isolation & purification , DNA-Binding Proteins/metabolism , Escherichia coli , Immunohistochemistry , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Pituitary Gland/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Transcription Factor Pit-1 , Transcription Factors/isolation & purification , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...